Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Hugo Robays"'
Autor:
Annemie Somers, H Yaras, Ludo Willems, Paul M. Tulkens, I Vanden Bremt, Anne Spinewine, Jean-Daniel Hecq, Isabel Spriet, Hugo Robays, M Haelterman, Stephane Steurbaut, M Dhoore
Publikováno v:
Acta clinica Belgica, p. 1-7 (2018)
Objectives The goal is to develop clinical pharmacy in the Belgian hospitals to improve drug efficacy and to reduce drug-related problems. Methods From 2007 to 2014, financial support was provided by the Belgian federal government for the development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33cfeecf8d23fe77a8093e4f889fe100
https://hdl.handle.net/20.500.14017/62ab4302-c5a5-4a27-bd7f-269ff2c4767b
https://hdl.handle.net/20.500.14017/62ab4302-c5a5-4a27-bd7f-269ff2c4767b
Autor:
Dirk Vogelaers, Barbara Claus, Filip De Turck, Hugo Robays, Johan Decruyenaere, Kristof Steurbaut, Kirsten Colpaert
Publikováno v:
International Journal of Clinical Pharmacy. 37:387-394
Background Critically ill patients are vulnerable to dosing errors. We developed an electronic Antimicrobial Dose alert based upon Creatinine clearance (ADC-alert), which gives daily antimicrobial dosing advice based upon the 24-h creatinine clearanc
Autor:
Johan Decruyenaere, Jan J. De Waele, Kirsten Colpaert, Hugo Robays, Barbara Claus, Eric Hoste
Publikováno v:
Journal of Critical Care. 28:695-700
We describe incidence and patient factors associated with augmented renal clearance (ARC) in adult intensive care unit (ICU) patients.A prospective observational study in a mixed cohort of surgical and medical ICU patients receiving antimicrobial the
Autor:
Annemie Somers, Mirko Petrovic, Georges Van Maele, Peter De Paepe, Katrina Perehudoff, Hugo Robays
Publikováno v:
Clinical Interventions in Aging, Vol Volume 8, Pp 703-709 (2013)
Clinical Interventions in Aging
Clinical Interventions in Aging
Annemie Somers,1 Hugo Robays,1 Peter De Paepe,2 Georges Van Maele,3 Katrina Perehudoff,4 Mirko Petrovic41Department of Pharmacy, Ghent University Hospital, Ghent, Belgium; 2Department of Emergency Medicine, Ghent University Hospital, Ghent, Belgium;
Autor:
Alain Verstraete, Jef Willems, Sven C. van Dijkman, Joris R. Delanghe, Peter De Paepe, Annick De Jaeger, Hugo Robays, Johan Vande Walle, Pieter De Cock, Mieke Carlier, Oscar Della Pasqua
Publikováno v:
The Journal of antimicrobial chemotherapy. 72(7)
Objectives: To characterize the population pharmacokinetics of piperacillin and tazobactam in critically ill infants and children, in order to develop an evidence-based dosing regimen. / Patients and methods: This pharmacokinetic study enrolled patie
Autor:
Hugo Robays, Rik Verhaeghe, Franky Buyle, Katleen Baldewijns, Roos Colman, Ann Van Hecke, Aurélie Van Lancker
Publikováno v:
Journal of advanced nursing. 72(9)
Aim To evaluate the effectiveness of an e-learning course compared with a face-to-face lecture on medication calculation. Background The current knowledge on medication calculation of nursing students and nurses is insufficient to provide safe care.
Autor:
Mirko Petrovic, G. Van Maele, Annemie Somers, Hugo Robays, Marcus Bogaert, R. Vander Stichele
Publikováno v:
The journal of nutrition, health & aging. 14:477-482
To investigate the frequency and type of drug related problems (DRPs) in geriatric patients (65 years), and to assess their contribution to hospital admission; to explore the appropriateness of drug therapy according to the Beers' criteria.Cross-sect
Autor:
Alain Verstraete, Joseph F. Standing, Peter De Paepe, Evelyn Dhont, Pieter De Cock, Mieke Carlier, Annick De Jaeger, Hugo Robays, Charlotte I. S. Barker, Joris R. Delanghe
There is little data available to guide amoxicillin-clavulanic acid dosing in critically ill children. The primary objective of this study was to investigate the pharmacokinetics of both compounds in this pediatric subpopulation. Patients admitted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f3eec02b82f798f7b5465df3fb8380
https://europepmc.org/articles/PMC4604416/
https://europepmc.org/articles/PMC4604416/
Publikováno v:
Drug Safety. 29:911-1010
Publikováno v:
Drug Safety. 29:911-1010